A description of the latest methods of oncological and hematological diagnostics, such as immunological, molecular genetic and histological essays. All methods are described in principle in their different variations and compared with regard to their effectiveness and cost. Written for scientists, clinicians and personnel in research, specialised and routine diagnostic laboratories in hospitals, this book satisfies the increased demand for information on new methods in hematology and oncology.
Advances in Cancer Research, Volume 139, provides invaluable information on the exciting and fast-moving field of cancer research. Original reviews are presented on a variety of topics relating to the rapidly developing intersection between nanotechnology and cancer research, with unique sections in the new release focusing on Exosomes as a theranostic for lung cancer, Nanotechnology and cancer immunotherapy, Ultrasound imaging agents and delivery systems, Dendronized systems for the delivery of chemotherapeutics, Thermosensitive liposomes for image-guided drug delivery, Supramolecular Chemistry in Tumor Analysis and Drug Delivery, Gold nanoparticles for delivery of cancer therapeutics, and Single cell barcode microchip for cancer research and therapy. Provides the latest information on cancer research Offers outstanding and original reviews on a range of cancer research topics Serves as an indispensable reference for researchers and students alike
Atlas of Diagnostic Oncology, 4th Edition, by Arthur T. Skarin, MD, FACP, FCCP, provides the guidance you need to diagnose a full range of neoplastic conditions with greater accuracy for better patient outcomes. An unrivaled collection of more than 2,500 images and drawings—combined with succinct, clinically focused text—equips you with essential information on pathology, diagnostic studies, staging, and clinical manifestations. New discussions on modern diagnostic PET imaging of cancer, and expanded coverage on the side effects of chemotherapy, bring you up to date on the issues impacting research and treatment. Expert Consult functionality—new to this edition—further enhances your reference power with convenient online access to the complete contents of the text, along with case studies that demonstrate effective approaches to diagnosis. A superb collection of more than 2,500 images encompasses the full spectrum of pathologic and radiologic studies, staging, and clinical manifestations, highlighting the pathologic anatomy of common clinical entities. A consistent chapter organization covers each disease’s incidence, epidemiology, etiology, and histopathology — as well as molecular biology, clinical features, diagnostic studies, and current clinical and pathologic staging — providing all the assistance you need to evaluate and monitor your patients effectively. This unique pictorial resource is a superb complement to treatment handbooks and major oncological texts. Expert Consult functionality provides online access to the complete text, fully searchable, with illustrations downloadable for your personal presentations, and case studies keyed to the book, at expertconsult.com. Completely updated chapters covering the newest genetic markers, imaging modalities, and pathologic techniques enable you to get the best results from today’s diagnostic tools. An expanded chapter on evaluating the side effects of chemotherapy, with additional images of reactions to the newest regimens, alerts you to potential common and uncommon side effects. Two new chapters address the complications of cancer and modern use of diagnostic PET scans, keeping you up to date on these hotly debated topics in the oncology community. A third new chapter covers malignant mesothelioma of the lung, plus other sites. Your purchase entitles you to access the web site until the next edition is published, or until the current edition is no longer offered for sale by Elsevier, whichever occurs first. Elsevier reserves the right to offer a suitable replacement product (such as a downloadable or CD-ROM-based electronic version) should access to the web site be discontinued.
Molecular Testing in Cancer provides a state of the art review of clinically relevant molecular pathology in cancer. The book provides a brief, easy to read review of commonly employed diagnostic molecular techniques including recently developed "next generation" analytic tools, and offers a system-based run-through of the utility of molecular testing in individual cancer types, as well as reviewing current markers in cancer diagnosis, prognosis, and management. The volume also provides a prospective for the future which includes recently characterized and emerging biomarkers. Written by experts in the field, Molecular Testing in Cancer serves as a useful and comprehensive resource for pathologists, hematologists, laboratory technicians and molecular scientists.
There is no field of medicine in which advances in therapy have been so closely linked to a better understanding of molecular medicine than in the area of hematologic malignancies. Diagnostic and Therapeutic Advances in Hematologic Malignancies will provide practitioners and academic clinicians with a better understanding of the constant evolving concepts in this area.
Infections are among the most frequent complications in patients with hematological malignancies and in those undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation. A profound knowledge on the epidemiology, diagnostic approaches, treatment modalities and prophylactic strategies is essential for the clinical management of these complications in patients who are often severely immunocompromised owing to their underlying diseases and in particular, the intensive myelosuppressive chemo and immunotherapy. This textbook provides a clinically oriented, compact and up-to-date overview on infections in hematology patients and their management. The typical pathogens to be considered in different subgroups of patients are identified and further aspects of the microbiological background are explored. Clinical, imaging, and laboratory-based diagnostic techniques are discussed and therapeutic strategies appropriate to different situations are then presented, with due attention to the pitfalls, toxicities and interactions that can arise during antimicrobial treatment. Strategies to prevent infection are also outlined, encompassing antimicrobial prophylaxis, isolation procedures, hospital hygiene, protective immunization and the use of hematopoietic growth factors.
The Washington Manual Subspecialty Consult Series is designed to provide quick access to the essential information needed to evaluate a patient on a subspecialty consult service. The Washington Manual of Hematology and Oncology subspecialty consult has been completely reviewed, revised, and follows the bulleted format and template of The Washington Manual of Medical Therapeutics, 33/e to allow for quick,readily accessible information. This edition has been updated to include new standards in the treatment of malignancies and hematologic disorders, mechanisms of action of new therapeutic agents, and the current use of molecular prognostic factors. The information in each chapter is now presented in a consistent format, with important references cited. The Manual is a practical reference for fellows, residents, and medical students rotating on hematology and oncology subspecialty services. Most of the authors are hematology-oncology fellows or internal medicine residents, the physicians who have recent experience with the issues and questions that arise in the course of training in these subspecialties. Primary care practitioners and other health care professionals also will find this manual useful as a quick reference source in hematology and oncology. Features include: New, templated format same as The Washington University Medical Therapeutics, 33e Contains synopsis of symptoms, signs, and problems encountered in their daily workflow in a bulleted format for quick salient points Includes new standards in the treatment of malignancies and hematologic disorders, mechanisms of action of new therapeutic agents, and the current use of molecular prognostic factors
CANCER CONSULT New edition covering the specialties of hematology, oncology and cellular therapy, now in two volumes Cancer Consult: Expertise in Clinical Practice, Volume 2: Neoplastic Hematology & Cellular Therapy, Second Edition includes hundreds of answers to practice-based questions covering the new principles of diagnosis, classification, staging, treatment, and outcomes in the rapidly advancing field of cancer. This textbook series also provides expert guidance in the areas of cancer-related uncertainties and controversies, including experience-based discussions. The book’s smaller size allows for easy access during medical rounds. This volume also includes: Up-to-date clinically relevant information on the very latest topics such as molecular techniques, targeted therapies, immunotherapy, BMT, CAR T-cell therapy and translational cancer research Sections on ALL, AML, myeloid neoplasms, CLL, Hodgkin’s and Non-Hodgkin’s lymphomas, amongst other topics Streamlined, engaging content to make finding information easier and less time consuming for the reader Concise and practical expert perspectives that reference key studies References to the latest NCCN, ESMO, ASH, ASTCT, EBMT and other national guidelines With its powerful focus on pragmatic clinical diagnostic, therapeutic and prognostic approaches, Cancer Consult: Expertise in Clinical Practice, Volume 2: Neoplastic Hematology & Cellular Therapy, Second Edition will help keep hematology, oncology and cellular therapy practitioners up-to-date, bridging the gaps between journal and reference literature, conferences, and their existing knowledge base. It also offers clinicians, trainees, and fellows an excellent opportunity to enhance their preparation for the ABIM, hematology and oncology fellowship and recertification exams.
Master oncology CPT® and HCPCS Level II procedure codes, with time to spare. Get on the fast track with the Coders’ Specialty Guide 2025: Oncology & Hematology. You’ll improve your productivity and reporting accuracy by having all the information you need about a code already neatly organized for you for quick reference — code descriptors, NCCI edits, ICD-10 cross references, RVUs, anatomical illustrations, Medicare fee amounts for both physicians and hospitals, and expert coding tips. Plus, a description of the procedure in easy-to-understand terms, so you can confidently translate your providers’ notes into the correct codes. Ace your oncology and hematology procedure reporting with features like: Oncology and hematology CPT® and HCPCS Level II procedure and service codes, including new and revised 2025 codes Official descriptors for Category I-III CPT® codes Lay term description for each procedure Fail-safe coding and billing advice for specific codes CPT® and HCPCS Level II modifier crosswalk for procedures Medicare physician fee schedule (physicians and hospitals) with RVUs Coding indicators (pre-, post-, intra-operative, global periods, and diagnostic tests) NCCI edits to avoid bundling issues Appendix with medical terms ICD-10-CM-to-CPT® crosswalks to help you effectively code procedures Comprehensive code index with page numbers for quicker code lookup Color-coded tabs to help you navigate easily Detailed anatomical illustrations *CPT® is a registered trademark of the American Medical Association.
Master oncology CPT® and HCPCS Level II procedure codes, with time to spare. Get on the fast track with the Coders’ Specialty Guide 2024: Oncology & Hematology. You’ll improve your productivity and reporting accuracy by having all the information you need about a code already neatly organized for you for quick reference — code descriptors, NCCI edits, ICD-10 cross references, RVUs, anatomical illustrations, Medicare fee amounts for both physicians and hospitals, and expert coding tips. Plus, a description of the procedure in easy-to-understand terms, so you can confidently translate your providers’ notes into the correct codes. Ace your oncology and hematology procedure reporting with features like: Oncology and hematology CPT® and HCPCS Level II procedure and service codes, including new and revised 2024 codes Official descriptors for Category I-III CPT® codes Lay term description for each procedure Fail-safe coding and billing advice for specific codes CPT® and HCPCS Level II modifier crosswalk for procedures Medicare physician fee schedule (physicians and hospitals) with RVUs Coding indicators (pre-, post-, intra-operative, global periods, and diagnostic tests) NCCI edits to avoid bundling issues Appendix with medical terms ICD-10-CM-to-CPT® crosswalks to help you effectively code procedures Comprehensive code index with page numbers for quicker code lookup Color-coded tabs to help you navigate easily Detailed anatomical illustrations *CPT® is a registered trademark of the American Medical Association.
